Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06880705 · ClinicalTrials.gov registry record · NA

The Trans-Led Care Study

A NA study of Substance Abuse and Human Immunodeficiency Virus (HIV), sponsored by Illinois Institute of Technology.

Recruiting
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT06880705 is a NA study of Substance Abuse and Human Immunodeficiency Virus (HIV) that is actively recruiting participants, run by Illinois Institute of Technology. The registered enrollment target is 124 participants, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06880705, a NA study of Substance Abuse and Human Immunodeficiency Virus (HIV), is actively recruiting participants, sponsored by Illinois Institute of Technology.

RECRUITING
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Therapy or "ACT" which is a type of mental health counseling that focuses on using mindfulness skills to connect a person to their values and improve their mental health. The TLC Program was developed by transgender and gender diverse community members, mental health providers, and researchers.

Conditions Studied

Substance Abuse Human Immunodeficiency Virus (HIV) Substance Use Disorder (SUD) Substance Use (Drugs, Alcohol) Substance Addiction

Interventions

  • BEHAVIORAL The TLC Program

Study Locations (1)

Illinois

  • Illinois Institute of Technology - Chicago

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2025-02-10
Est. Completion 2027-07-31
Phase NA

Sponsor

Illinois Institute of Technology

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06880705

The ClinicalTrials.gov registry entry for NCT06880705 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The listed sponsor is Illinois Institute of Technology, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which The TLC Program is the first listed.

NCT06880705 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06880705 about?

NCT06880705 is a clinical study titled "The Trans-Led Care Study". This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Therapy or "ACT" which is a type of mental health counseling that focuses on using mindfulness skills to...

What is the current status of trial NCT06880705?

This trial is currently recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2025-02-10. Estimated completion is 2027-07-31.

What conditions does trial NCT06880705 study?

This clinical trial studies the following conditions: Substance Abuse, Human Immunodeficiency Virus (HIV), Substance Use Disorder (SUD), Substance Use (Drugs, Alcohol), Substance Addiction.

What interventions are being tested in trial NCT06880705?

The interventions under investigation include: The TLC Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06880705?

This trial is sponsored by Illinois Institute of Technology, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06880705 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Substance Abuse

All registered trials for this condition

Human Immunodeficiency Virus (HIV)

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.